The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Indium (111In) DTPA 37MBq/ml Solution for Injection

Curium Netherlands B.V.PA0690/009/001

Main Information

Trade NameIndium (111In) DTPA 37MBq/ml Solution for Injection
Active SubstancesIndium (111 in)
Dosage FormSolution for injection
Licence HolderCurium Netherlands B.V.
Licence NumberPA0690/009/001

Group Information

ATC CodeV09AX01 indium (111In) pentetic acid


License statusAuthorised
Licence Issued31/03/2004
Legal statusProduct subject to Restricted Prescription (C)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see: Summary of Product Characteristics, section 4.2).
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back